id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-0223-0007,FDA,FDA-2024-E-0223,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-09-19T04:00:00Z,2025,9,2025-09-19T04:00:00Z,,2025-09-19T17:32:43Z,,0,0,09000064b8fb006b
FDA-2024-E-0223-0006,FDA,FDA-2024-E-0223,Determination of Regulatory Review Period for Purposes of Patent Extension; OMISIRGE,Notice,Determinations,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2024-12-30T17:17:19Z,2024-31262,0,0,0900006486894d5f
FDA-2024-E-0223-0005,FDA,FDA-2024-E-0223,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2024-12-27T05:00:00Z,2024,12,2024-12-27T05:00:00Z,,2024-12-27T14:12:00Z,,0,0,09000064868910a1
FDA-2024-E-0223-0004,FDA,FDA-2024-E-0223,Order Granting Interim Extension,Other,Letter(s),2024-07-31T04:00:00Z,2024,7,2024-07-31T04:00:00Z,,2024-07-31T12:19:07Z,,0,0,0900006486605f0c
FDA-2024-E-0223-0003,FDA,FDA-2024-E-0223,Letter from FDA CDER to U. S. Patent and Trademark Office,Other,Letter(s),2024-04-08T04:00:00Z,2024,4,2024-04-08T04:00:00Z,,2024-04-08T14:44:20Z,,0,0,09000064864c0119
FDA-2024-E-0223-0002,FDA,FDA-2024-E-0223,Patent Term Extension Application from Cooley LLP (on behalf of Gamida Cell Ltd.),Other,Application,2024-01-25T05:00:00Z,2024,1,2024-01-25T05:00:00Z,,2024-01-25T19:24:34Z,,0,0,09000064863a8a1b
FDA-2024-E-0223-0001,FDA,FDA-2024-E-0223,Letter from U.S. Patent Trademark Office to FDA CDER,Other,Letter(s),2024-01-25T05:00:00Z,2024,1,2024-01-25T05:00:00Z,,2024-01-25T19:22:20Z,,0,0,0900006486396437